185 related articles for article (PubMed ID: 8924055)
1. Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.
Napoli C; Chiariello M; Palumbo G; Ambrosio G
Cardiovasc Drugs Ther; 1996 Sep; 10(4):417-24. PubMed ID: 8924055
[TBL] [Abstract][Full Text] [Related]
2. [Calcium channel blockers inhibit human low-density lipoprotein peroxidation induced by oxygen free radicals in vitro].
Napoli C; Ambrosio G; Palumbo G; Chiariello P; Chiariello M
Cardiologia; 1992 Nov; 37(11):801-4. PubMed ID: 1298553
[TBL] [Abstract][Full Text] [Related]
3. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
Nègre-Salvayre A; Salvayre R
Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
[TBL] [Abstract][Full Text] [Related]
4. [Protection by blockers against human low density lipoprotein peroxidation induced by oxygen free radicals].
Napoli C; Ambrosio G; Chiariello P; Palumbo G; Chiariello M
G Ital Cardiol; 1994 Apr; 24(4):361-6. PubMed ID: 7914499
[TBL] [Abstract][Full Text] [Related]
5. 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.
Napoli C; Salomone S; Godfraind T; Palinski W; Capuzzi DM; Palumbo G; D'Armiento FP; Donzelli R; de Nigris F; Capizzi RL; Mancini M; Gonnella JS; Bianchi A
Stroke; 1999 Sep; 30(9):1907-15. PubMed ID: 10471444
[TBL] [Abstract][Full Text] [Related]
6. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
Rojstaczer N; Triggle DJ
Biochem Pharmacol; 1996 Jan; 51(2):141-50. PubMed ID: 8615882
[TBL] [Abstract][Full Text] [Related]
7. Antiperoxidative actions of calcium antagonists and atherogenesis.
Henry PD
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S6-10. PubMed ID: 1723459
[TBL] [Abstract][Full Text] [Related]
8. [Human low-density lipoproteins are peroxidized by free radicals via chain reactions triggered by the superoxide radical].
Napoli C; Ambrosio G; Palumbo G; Elia PP; Chiariello M
Cardiologia; 1991 Jul; 36(7):527-32. PubMed ID: 1665102
[TBL] [Abstract][Full Text] [Related]
9. In vitro calcium antagonistic and antioxidant effects of Org 13061 and its enantiomers, new potential antiatherosclerotic compounds.
Beaughard M; Chevalier A; Dureng G; Leboeuf J; Massingham R; Mazur A; Rayssiguier Y; Winslow E
Fundam Clin Pharmacol; 1997; 11(5):416-26. PubMed ID: 9342595
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.
Sevanian A; Shen L; Ursini F
Pharm Res; 2000 Aug; 17(8):999-1006. PubMed ID: 11028948
[TBL] [Abstract][Full Text] [Related]
11. A high concentration of melatonin inhibits in vitro LDL peroxidation but not oxidized LDL toxicity toward cultured endothelial cells.
Walters-Laporte E; Furman C; Fouquet S; Martin-Nizard F; Lestavel S; Gozzo A; Lesieur D; Fruchart JC; Duriez P; Teissier E
J Cardiovasc Pharmacol; 1998 Oct; 32(4):582-92. PubMed ID: 9781926
[TBL] [Abstract][Full Text] [Related]
12. Comparative cytoprotective effect of dihydropyridine calcium channel blockers against the toxicity of oxidized low density lipoprotein for cultured lymphoid cells.
Nègre-Salvayre A; Fitoussi G; Troly M; Salvayre R
Biochem Pharmacol; 1992 Dec; 44(12):2379-86. PubMed ID: 1472103
[TBL] [Abstract][Full Text] [Related]
13. Calcium antagonists prevent monocyte and endothelial cell-induced modification of low density lipoproteins.
Breugnot C; Mazière C; Auclair M; Mora L; Ronveaux MF; Salmon S; Santus R; Morlière P; Lenaers A; Mazière JC
Free Radic Res Commun; 1991; 15(2):91-100. PubMed ID: 1756990
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein.
Napoli C; Triggiani M; Palumbo G; Condorelli M; Chiariello M; Ambrosio G
Basic Res Cardiol; 1997 Apr; 92(2):96-105. PubMed ID: 9166989
[TBL] [Abstract][Full Text] [Related]
15. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
Lupo E; Locher R; Weisser B; Vetter W
Biochem Biophys Res Commun; 1994 Sep; 203(3):1803-8. PubMed ID: 7945331
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients. Comparative effects of enalapril versus nifedipine: a randomized cross-over over study.
Rachmani R; Lidar M; Brosh D; Levi Z; Ravid M
Diabetes Res Clin Pract; 2000 May; 48(2):139-45. PubMed ID: 10802151
[TBL] [Abstract][Full Text] [Related]
17. Antiatherosclerotic and antiatherogenic effects of a calcium antagonist plus statin combination: amlodipine and lovastatin.
Orekhov AN; Tertov VV; Sobenin IA; Akhmedzhanov NM; Pivovarova EM
Int J Cardiol; 1997 Dec; 62 Suppl 2():S67-77. PubMed ID: 9488197
[TBL] [Abstract][Full Text] [Related]
18. Calcium antagonists and atherosclerosis protection in hypertension.
Hernández RH; Armas-Hernández MJ; Velasco M; Israili ZH; Armas-Padilla MC
Am J Ther; 2003; 10(6):409-14. PubMed ID: 14624278
[TBL] [Abstract][Full Text] [Related]
19. Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
Bouscarel B; Ceryak S; Fromm H
Biochim Biophys Acta; 1996 Jun; 1301(3):230-6. PubMed ID: 8664333
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of daunorubicin-augmented microsomal lipid peroxidation and oxygen consumption by calcium channel antagonists.
Engineer FN; Sridhar R
Biochem Biophys Res Commun; 1991 Sep; 179(2):1101-6. PubMed ID: 1654899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
